Phillip Gambel

Array ( [id] => 9634319 [patent_doc_number] => 20140212427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'Anti-Properdin Antibodies and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/130250 [patent_app_country] => US [patent_app_date] => 2012-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 23757 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14130250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11356405 [patent_doc_number] => 09533044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-03 [patent_title] => 'Methods of treating inflammatory disorders using high concentration natalizumab compositions' [patent_app_type] => utility [patent_app_number] => 13/530879 [patent_app_country] => US [patent_app_date] => 2012-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22278 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8755622 [patent_doc_number] => 20130089927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'Hematopoietic Cell E-Selectin/L-Selectin Ligand Polypeptides and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/529530 [patent_app_country] => US [patent_app_date] => 2012-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 26805 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13529530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8696920 [patent_doc_number] => 20130058929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'FUSION PROTEINS FOR INHIBITION AND DISSOLUTION OF COAGULATION OF THROMBI' [patent_app_type] => utility [patent_app_number] => 13/528125 [patent_app_country] => US [patent_app_date] => 2012-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12940 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13528125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8696950 [patent_doc_number] => 20130058959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'HEMATOPOIETIC CELL SELECTIN LIGAND POLYPEPTIDES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/528069 [patent_app_country] => US [patent_app_date] => 2012-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 34127 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13528069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8697324 [patent_doc_number] => 20130059333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'HEMATOPOIETIC CELL SELECTIN LIGAND POLYPEPTIDES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/528143 [patent_app_country] => US [patent_app_date] => 2012-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 34154 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13528143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9354774 [patent_doc_number] => 08673305 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Methods of treatment with antibodies against the extracellular loops of C5aR' [patent_app_type] => utility [patent_app_number] => 13/525092 [patent_app_country] => US [patent_app_date] => 2012-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18137 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13525092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8976019 [patent_doc_number] => 20130209449 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-08-15 [patent_title] => 'ANTI-PSGL-1 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/494398 [patent_app_country] => US [patent_app_date] => 2012-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22609 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13494398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8976019 [patent_doc_number] => 20130209449 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-08-15 [patent_title] => 'ANTI-PSGL-1 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/494398 [patent_app_country] => US [patent_app_date] => 2012-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22609 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13494398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8585692 [patent_doc_number] => 20130004514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'THERAPEUTIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/490093 [patent_app_country] => US [patent_app_date] => 2012-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27771 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13490093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10601287 [patent_doc_number] => 09321841 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Humanised anti-CD52 antibodies' [patent_app_type] => utility [patent_app_number] => 14/123349 [patent_app_country] => US [patent_app_date] => 2012-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 15 [patent_no_of_words] => 9105 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919144 [patent_doc_number] => 20140322164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'METHOD OF ASSESSING RISK OF PML' [patent_app_type] => utility [patent_app_number] => 14/122754 [patent_app_country] => US [patent_app_date] => 2012-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 29671 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8502075 [patent_doc_number] => 20120301483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'COMPLEMENT PATHWAY INHIBITORS BINDING TO C5 AND C5A WITHOUT PREVENTING THE FORMATION OF C' [patent_app_type] => utility [patent_app_number] => 13/482328 [patent_app_country] => US [patent_app_date] => 2012-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9404 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13482328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8907252 [patent_doc_number] => RE044359 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2013-07-09 [patent_title] => 'Nucleic acid molecules encoding anti-P-selectin antibodies' [patent_app_type] => reissue [patent_app_number] => 13/471899 [patent_app_country] => US [patent_app_date] => 2012-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 23676 [patent_no_of_claims] => 169 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13471899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8381397 [patent_doc_number] => 20120225014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'ANTIBODIES TO CD40' [patent_app_type] => utility [patent_app_number] => 13/471395 [patent_app_country] => US [patent_app_date] => 2012-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 42104 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13471395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8452763 [patent_doc_number] => 20120263710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'ADMINISTERING ANTI-PLACENTAL GROWTH FACTOR ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/470615 [patent_app_country] => US [patent_app_date] => 2012-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14741 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8393144 [patent_doc_number] => 20120230985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/461253 [patent_app_country] => US [patent_app_date] => 2012-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17561 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13461253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8502080 [patent_doc_number] => 20120301488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'ANTI-CD40 ANTIBODIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/458730 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 31290 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11250389 [patent_doc_number] => 09475879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-25 [patent_title] => 'Antibody polypeptides that antagonize CD40' [patent_app_type] => utility [patent_app_number] => 14/112049 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 44336 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112049 [rel_patent_id] =>[rel_patent_doc_number] =>)